HumaniPSC-DerivedNeuralStemCellsthathavebeengeneticallyeditedusingCRISPR-Cas9technologytointroducetheP301Lmutation(CCG>CTG)intotheMAPTgene.ThislineishomozygousfortheP301Lmutationsobothallelescontainthemutation.Clickontheproductimagestoseethedataandfurtherdetails.
TheP301LmutationMAPThasbeenimplicatedinfrontotemporaldementiaandparkinsonism(Dumanchinetal.,1998).Themutationaffectsonlythe4RisoformsofMAPTsincetheexoncontainingthemutationissplicedoutof3Risoforms(Huttonetal.,1998).AggregatedMAPT/tauproteininaffectedpatientsconsistedmainlyofthe4Risoform(Huttonetal.,1998).TheP301LmutationpromotesaggregationofMAPT/tauproteinintoorderedpairedhelicalfilamentsandbetasheetformationinvitro(vonBergenetal.,2001).
| Startingmaterial | Dermalfibroblast |
| Donorgender | Female |
| Donorageatsampling | 64yrs |
| Karyotype | Normal |
| Reprogrammingmethod | Episomalvector |
| Inductionmethod | Monolayer&chemicallydefinedmedium |
| Geneticmodification | HomozygousfortheMAPTP301Lmutation(CCG>CTG) |
| Geneticmodification | Containsapuromycinresistancecassette(intronic) |
| Size | ≥1.5millioncells |
| Kitcomponents | 1vialofNeuralStemCells(≥1.5millioncells)and1bottleofNeuralPlating-XFMedium(30mL) |
| Growthproperties | Adherent |
| Shippingconditions | Dryice |
| Storageconditions | Liquidnitrogen |



